Articles tagged with Biomedical Research Funding
A study from Michigan Medicine reveals a connection between neutrophil activation and severe cytokine release syndrome (CRS), a potentially life-threatening reaction to CAR T-Cell therapy. Researchers identified biomarkers of NETosis, a process in which neutrophils create webs that may contribute to CRS.
Researchers at Texas A&M University developed vessel-chip technology to create a platform for preclinical drug discovery, reducing the need for animal testing. The system mimics human circulatory systems using tissue-engineered microfluidic devices.
Dr. Melissa Grunlan's team creates regenerative osteochondral plugs, a potential off-the-shelf device to treat OCDs and avoid total knee replacement surgery. The technology offers an alternative to autografting or total knee replacement, providing immediate support for joint function and potentially reducing post-operative complications.
Three FAU researchers have received $1M in FDOH grants to develop innovative approaches against Alzheimer's disease. Mare Cudic aims to explore the link between glycosylation and neuroinflammation, while Ruth Tappen develops an online screening tool for older drivers with cognitive decline.
A new NIH grant will investigate biological processes that contribute to defects in immune response in the eyes of those with diabetes. Researchers aim to understand why diabetic patients are more susceptible to corneal infections and identify methods to reverse these effects.
The ADA Forsyth Institute has ranked as the top oral health research institution on the East Coast, receiving significant funding from the National Institute of Dental and Craniofacial Research. The institute's researchers have consistently demonstrated excellence in their field, with a strong track record of innovation and impact.
Alexander Gow is studying the disease's effects on oligodendrocytes to provide new insight into the development and origins of MS. He aims to develop improved treatments by identifying a protein called Trb3 that may be a good drug target for the disease.
Researchers at George Mason University's Biomedical Research Laboratory are conducting Plaque Reduction Neutralization Tests (PRNTs) on patient serum samples from Athari BioSciences. The study aims to analyze the neutralizing ability of antibodies against SARS-CoV-2.
Researchers have developed a pressure-alternating shoe insole that provides periods of rest to the soft tissues, thereby reducing the risk of diabetic foot ulcers. This innovative technology aims to mitigate the risk of complications from poor circulation and foot sores.
The REACTIVA project aims to establish a new strategy for cardiac regeneration based on reactivating the heart's dormant endogenous mechanism. Researchers will investigate the role of diploid adult cardiomyocytes in cardiac regeneration and use this knowledge to induce their activation.
A team of scientists at Tokyo University of Science has discovered a novel substituent migration reaction that enables the creation of complex benzofurans. This breakthrough synthesis method uses alkynyl sulfoxide and trifluoroacetic anhydride to produce highly functionalized benzofurans with high yields.
Researchers have developed a urine-based test that detects pieces of DNA fragments released by head and neck tumors, providing a non-invasive alternative to traditional blood-based biomarker tests. The test has been shown to detect cancer recurrences far earlier than would typically happen based on clinical imaging.
Researchers at Case Western Reserve, UNC/NCSU, and Pitt aim to develop an injectable nanotechnology that mimics platelet function to stabilize blood clots in traumatic injuries. The technology has the potential to stop hemorrhage and improve survival rates in emergency situations.
Jos Malda receives ERC grant to crack cartilage code and create regenerative treatments. By studying cartilage 'organ-on-a-chip' models and animal cartilages, researchers aim to recreate the intricate internal structure of cartilage.
Thorsten Hoppe and Jens Brüning received 2.5 million euros in funding from the European Research Council to investigate protein degradation and neural circuits of metabolic control, respectively. Their projects focus on preventing neurodegeneration and developing new drugs for obesity treatment.
A new research project, PHOTOZYME, aims to develop photobiocatalytic tools to convert basic chemicals into chiral molecules. The project combines biocatalysis, photochemistry, and directed evolution to create sustainable molecular synthesis.
The WVU Institute for Community and Rural Health is leading a five-year, $8.5 million cooperative agreement grant to support underserved farmers in West Virginia, Pennsylvania, Virginia, and North Carolina. The project aims to increase agricultural production, provide working capital, and create farm-to-institution markets.
University of Virginia researchers have identified a single gene on the Y chromosome that can account for the disease-promoting effects of Y chromosome loss. This discovery provides new avenues for understanding the causes of heart disease and could lead to a treatment for men with Y chromosome loss.
Researchers are developing a flexible online tool to navigate information used in the fight against deadly diarrheal diseases. The Plan-EO dashboard will provide real-time data on pathogen dynamics, allowing infectious disease experts and local leaders to make smart decisions and save lives.
Kessler Foundation and collaborators win $1 million prize for proof-of-concept study on tablet-type controller StimXS, designed to help individuals with spinal cord injuries manage autonomic functions. The team advances to Phase 3 of the NIH Common Fund's Neuromod Prize competition.
Researchers have identified a potential path to eliminate the viral reservoir that prevents people from being completely cured of HIV. A new drug candidate, called a proteolysis targeting chimeras (PROTAC) molecule, triggers the degradation of the Nef protein, which suppresses HIV replication and restores immune system detection. This ...
The Sylvester Comprehensive Cancer Center researchers will investigate the genetics behind endometrial cancer in Black women and its awareness among different populations. They aim to identify high-risk women, understand hereditary mutations, and raise physician awareness.
Virginia Tech researchers have received a five-year National Science Foundation grant to develop an open-source automated forecasting system for lakes. The system will enable real-time data collection and publishing, allowing researchers to predict water quality in lakes around the globe.
The USC CIRM ASCEND Center will offer organoids, single-cell analysis, and spatial transcriptomics services to the California research community. The center aims to facilitate collaboration, technology transfer, and a competent workforce in personalized medicine.
Researchers at Flinders University have discovered a bedtime nasal spray that can reduce the severity of sleep apnea in people and lower their blood pressure. The study found that the spray, which blocks potassium channels, improved oxygen levels and reduced markers of OSA severity in 7 out of 10 participants.
Research from UCSF found COVID antigens lingering in blood up to 14 months and tissue samples for over two years after infection. The persistence of these fragments may drive long COVID symptoms and associated risks.
Dr. Ryyna Ethell's lab at UC Riverside has been awarded a $2.4 million NIH grant to investigate the role of astrocytes in inhibitory synapse development and their connection to neurodevelopmental disorders like ADHD and autism.
A Boston College biologist is studying the mechanisms of viral insulins to develop novel therapeutics for a range of human diseases, including cancers. The researcher has identified six viruses that mimic human insulin and IGF-1, which can block an important receptor, leading to potential affordable treatments.
The Almodóvar lab is studying the link between HIV and pulmonary hypertension, a condition that increases pressure in lung arteries. By examining the interactions between different cell types and using a humanized mouse model, researchers hope to propose novel therapies to prevent lung diseases in people with HIV.
Rumbaugh's lab aims to understand the effects of dispersing bacteria from a biofilm on their susceptibility to antibiotics and on the host. They will use enzymes as tools to break up biofilms, allowing researchers to better comprehend the relationship between bacterial dispersal and infection outcomes.
A new study aims to enhance and prolong vaccine effectiveness by delivering adjuvants to white blood cells using lipid nanoparticles. The research, led by WVU professor Sharan Bobbala, has the potential to provide broader protection against evolving viruses and multiple diseases.
Researchers have engineered T cells with a mutation found in malignant lymphoma cells, making them more than 100 times potent at killing cancer cells. The new approach shows promise against solid tumors and could provide long-term immunity against cancer.
The American Heart Association's PREVENT risk calculator will be evaluated among diverse populations to assess its accuracy and fairness. The research aims to ensure that the tool provides accurate risk predictions for people from various racial, ethnic, and socioeconomic backgrounds.
A clinical trial is underway to help patients with opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) stick with medication treatment. The trial uses a patient-administered wearable device that delivers mild electrical stimulation to alleviate symptoms of both conditions.
A team of scientists from the Beckman Institute has received a $3 million grant to develop diagnostic tools and imaging agents for the early detection of Alzheimer's disease. They will use a combination of PET and MRI scans to target smaller beta-amyloid peptides and other signs of neuroinflammation and oxidative stress.
Researchers at Istituto Italiano di Tecnologia receive 5 million euros in funding to bridge gap between basic research and real-world applications. The projects aim to address key issues such as tumors, neurodevelopmental disabilities, and new quantum technologies.
Researchers aim to improve glioma treatment with direct light therapy that targets cancer cells without harming healthy ones. The project will investigate the efficacy and safety of this approach, potentially leading to improved treatment outcomes.
High levels of copper linked to poorer patient outcomes in clear cell renal cell carcinoma (ccRCC) patients, according to NIH-funded University of Cincinnati Cancer Center research. The study aims to identify copper's mechanisms and test potential new treatments for ccRCC.
This special issue highlights promising research projects developing scalable digital technology solutions for improved heart and brain health. Smartphone-based assessments and point-of-care echocardiography have shown promise in diverse populations, including those with latent rheumatic heart disease and dementia.
George Mason University's Ali Andalibi is set to receive funding from Perthera for the development of a tissue bank. The Perthera Tissue Bank will be stored in a controlled environment to ensure safe and proper storage conditions, with regular checks by the Principal Investigator, Co-Investigator, and staff.
Researchers from Johannes Gutenberg University Mainz and their French partners receive funding for two distinctive biology projects through the ANR-DFG program. The EVOMET project investigates plant metabolism, while the NeuroDevFunc project explores how fruit flies process visual motion generated by self-movement.
A team of researchers discovered a multiprotein complex involving NLRP3, AIM2, NLRC4, and Pyrin that drives PANoptosis, a type of programmed inflammatory cell death. The findings have implications for understanding inflammasome biology and identifying potential therapeutic targets.
Researchers found that the severity of muscle wasting depends on the location of the spinal cord injury. They also discovered that hypercortisolism, a hormonal imbalance, worsens muscle loss and can be targeted to rescue muscle tissue.
Researchers at the University of Virginia Health System discovered that tau proteins damage brain cells by warping their nuclei, altering gene function and increasing tau production. This finding could lead to new treatments for Alzheimer's disease and other tauopathies.
A $2 million three-year grant from the U.S. Department of Commerce will create a regional incubator for life sciences startups in South Carolina, providing them with expertise, resources, and networking opportunities.
The National Science Foundation has awarded Lehigh University $6 million to develop a comprehensive, inclusive and accessible research translation ecosystem. The award supports the university's work in engineering, science, health, humanities, business, education and other areas to translate discoveries into practical solutions.
Researchers at UVA Health System created an 'atlas of atherosclerosis' revealing critical processes that form harmful plaque buildup. The study provides unprecedented insights into atherosclerosis and its impact on coronary artery disease, heart attacks, and strokes.
A Philippine sea cucumber species has been found to contain diverse classes of valuable small molecules with potential biomedical applications. These bioactive compounds, including terpenoid glycosides and saponins, have reported anti-cancer benefits.
Researchers aim to determine optimal duration and intensity of behavioral interventions for childhood obesity among rural and minority children. The five-year study, funded by the Patient-Centered Outcomes Research Institute, will enroll 900 parent-child pairs and compare different 'dosing' combinations of face-to-face intervention time.
A research team at Iowa State University is developing a 'placenta-on-a-chip' model to study substance transport across the placental barrier. The project aims to integrate sensing platforms and imaging technology to advance personalized medicine and commercialization.
A team of researchers from Texas A&M University is developing a low-cost, safe, and controlled cancer treatment using programmable bacteria. The $20 million project aims to create an efficient bacterial therapeutic that can target cancer cells with high precision, reducing side effects and costs.
Researchers at Texas A&M University have developed a miniature, injectable glucose biosensor and wearable device that enables user-friendly, minimally-invasive continuous glucose monitoring. The device addresses challenges associated with existing CGMs, including size and skin tone compatibility.
The University of Basel has successfully treated over 100 patients with focal lesions and two advanced cases of knee OA, reporting beneficial outcomes. The N-TEC procedure uses autologous cartilage cells to grow new cartilage grafts for repairing damaged joints, offering an alternative to knee joint replacements.
Researchers at UMass Lowell found that anti-inflammatory bacteria were less abundant in people with Parkinson's disease, suggesting a potential biomarker for early diagnosis. A new study on Latinos may also uncover novel biomarkers for Alzheimer's disease.
Researchers aim to optimize digital weight-loss programs for rural populations by adding human components, such as weekly group video sessions and individual coaching calls. The goal is to help residents manage their weight and fight the obesity epidemic in areas with limited access to in-person programs.
Researchers at UTHealth Houston are studying the impact of circadian rhythm on heart attacks and cardiac surgery, with a focus on identifying novel therapies to protect the heart. They will investigate the role of key genes and signaling pathways in modulating daytime variations in cardiac injury.
The Southwest-Midwest Pediatric Device Innovation Consortium has supported over 200 pediatric device innovators and companies, developing several devices in the past five years. The consortium's portfolio includes real-world evidence research projects using digital tools for collecting and analyzing patient data.
Researchers found that patients with elevated NfL levels had a 91% higher risk of worsening disability with relapse within a year, and a 49% higher risk without relapse nearly two years later. The study suggests that interventions may prevent worsening symptoms by targeting nerve cell death.
Researchers are combining biology, physics, computer science, and engineering to design electric circuits that mimic the brain's adaptive behavior. The goal is to create a more efficient AI application that can learn from history and adapt without significant energy consumption.
The Center for Innovation and Translation of POC Technologies for Equitable Cancer Care will prioritize development of POC tests for oral, cervical and gastrointestinal cancers. CITEC's goal is to identify needed technologies, accelerate their development, evaluate their performance in diverse settings.